These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases. Martínez-Arribas F, Núñez MJ, Piqueras V, Lucas AR, Sánchez J, Tejerina A, Schneider J. Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306 [Abstract] [Full Text] [Related]
8. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters. Rosanelli GP, Steindorfer P, Wirnsberger GH, Klimpfinger M, Ratschek M, Puerstner P, Auner H, Berhold A. Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041 [Abstract] [Full Text] [Related]
9. Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Soares J, Pinto AE, Cunha CV, André S, Barão I, Sousa JM, Cravo M. Cancer; 1999 Jan 01; 85(1):112-8. PubMed ID: 9921982 [Abstract] [Full Text] [Related]
11. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer. Velanovich V. Am Surg; 1997 Apr 01; 63(4):330-3. PubMed ID: 9124752 [Abstract] [Full Text] [Related]
12. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Hedley DW, Rugg CA, Ng AB, Taylor IW. Cancer Res; 1984 Nov 01; 44(11):5395-8. PubMed ID: 6488193 [Abstract] [Full Text] [Related]
18. Prognostic value of DNA ploidy in breast cancer stage I-II. Cufer T, Lamovec J, Bracko M, Lindtner J, Us-Krasovec M. Neoplasma; 1997 Nov 01; 44(2):127-32. PubMed ID: 9201293 [Abstract] [Full Text] [Related]
19. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM. Gynecol Oncol; 1993 Feb 01; 48(2):232-5. PubMed ID: 8428696 [Abstract] [Full Text] [Related]